First Time Loading...

Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 9.47 USD -0.84% Market Closed
Updated: May 5, 2024

Income Statement

Earnings Waterfall
Centessa Pharmaceuticals PLC

Revenue
6.9m USD
Operating Expenses
-178.1m USD
Operating Income
-171.3m USD
Other Expenses
20.2m USD
Net Income
-151.1m USD

Income Statement
Centessa Pharmaceuticals PLC

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
7
N/A
Operating Income
Operating Expenses
(10)
(26)
(62)
(319)
(154)
(188)
(218)
(229)
(212)
(208)
(187)
(178)
(178)
Selling, General & Administrative
(1)
(9)
(18)
(30)
(43)
(49)
(55)
(54)
(55)
(57)
(55)
(55)
(54)
Research & Development
(9)
(17)
(33)
(57)
(96)
(122)
(158)
(169)
(155)
(151)
(131)
(123)
(124)
Other Operating Expenses
0
0
(11)
(232)
(15)
(17)
(6)
(6)
(2)
0
0
0
0
Operating Income
(10)
N/A
(26)
-151%
(62)
-137%
(319)
-413%
(154)
+52%
(188)
-22%
(218)
-16%
(229)
-5%
(212)
+7%
(208)
+2%
(187)
+10%
(178)
+5%
(171)
+4%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(1)
(3)
(4)
(6)
(7)
(5)
(4)
(2)
1
Non-Reccuring Items
0
(220)
(220)
0
(220)
0
0
0
0
0
0
0
0
Total Other Income
(0)
(0)
(3)
(5)
(6)
(5)
3
1
2
1
(6)
(5)
(5)
Pre-Tax Income
(11)
N/A
(247)
-2 218%
(286)
-16%
(324)
-13%
(381)
-18%
(196)
+49%
(220)
-12%
(234)
-6%
(217)
+7%
(213)
+2%
(197)
+7%
(184)
+6%
(176)
+4%
Net Income
Tax Provision
0
0
0
0
(0)
(0)
(0)
(0)
1
0
24
27
25
Income from Continuing Operations
(11)
(247)
(286)
(324)
(381)
(196)
(220)
(234)
(216)
(212)
(173)
(157)
(151)
Net Income (Common)
(11)
N/A
(247)
-2 218%
(286)
-16%
(324)
-13%
(381)
-18%
(196)
+49%
(220)
-12%
(234)
-6%
(216)
+8%
(212)
+2%
(173)
+19%
(157)
+9%
(151)
+4%
EPS (Diluted)
-0.12
N/A
-2.83
-2 258%
-3.91
-38%
-3.59
+8%
-5.07
-41%
-2.16
+57%
-2.33
-8%
-2.47
-6%
-2.31
+6%
-2.25
+3%
-1.82
+19%
-1.62
+11%
-1.57
+3%

See Also

Discover More